IMVAMUNE smallpox vaccine approved for monkeypox and related orthopoxvirus in Canada
by Press Release from Outbreak News Today on (#5AA8S)
Bavarian Nordic A/S announced today that Health Canada has expanded the approval of the Company's non-replicating smallpox vaccine, IMVAMUNE(R) to include additional indications - specifically, monkeypox and related orthopoxvirus infections and disease in adults 18 years of age and older determined to be at high risk for exposure. The extended approval was granted following assessment of [...]
The post IMVAMUNE smallpox vaccine approved for monkeypox and related orthopoxvirus in Canada appeared first on Outbreak News Today.